Search Results - "van Tilburg, E W"
-
1
Radiosynthesis of [11C]docetaxel
Published in Journal of labelled compounds & radiopharmaceuticals (15-10-2004)“…Docetaxel (Taxotere®) is an accepted chemotherapeutic agent for the treatment of breast cancer and non‐small cell lung cancers. A potential means of predicting…”
Get full text
Journal Article -
2
Improved and semi-automated GMP-compliant radiosynthesis of [ 11C]docetaxel
Published in Applied radiation and isotopes (01-10-2008)“…[ 11C]Docetaxel (Taxotere ®) has been synthesized via an improved synthesis route, which involves a more efficient intermediate removal of the excess…”
Get full text
Journal Article -
3
5‘-O-Alkyl Ethers of N,2-Substituted Adenosine Derivatives: Partial Agonists for the Adenosine A1 and A3 Receptors
Published in Journal of medicinal chemistry (30-08-2001)“…New N,5‘-di- and N,2,5‘-trisubstituted adenosine derivatives were synthesized in good overall yields. Appropriate 5-O-alkyl-substituted ribose moieties were…”
Get full text
Journal Article -
4
Substituted 4-phenyl-2-(phenylcarboxamido)-1,3-thiazole derivatives as antagonists for the adenosine A1 receptor
Published in Bioorganic & medicinal chemistry letters (06-08-2001)Get full text
Journal Article -
5
Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells studies on involvement of adenosine receptors and adenosine uptake
Published in Biochemical pharmacology (15-02-2001)“…The induction of apoptosis by adenosine was studied in the mouse neuroblastoma cell line N1E-115. Apoptosis was characterized by fluorescence and electron…”
Get full text
Journal Article -
6
Substituted 4-phenyl-2-(phenylcarboxamido)-1,3-thiazole derivatives as antagonists for the adenosine A(1) receptor
Published in Bioorganic & medicinal chemistry letters (06-08-2001)“…The synthesis and receptor binding of novel adenosine receptor antagonists is described. We found that non-xanthine 4-phenyl-2-(phenylcarboxamido)-1,3-thiazole…”
Get full text
Journal Article -
7
N6,5‘-Disubstituted Adenosine Derivatives as Partial Agonists for the Human Adenosine A3 Receptor
Published in Journal of medicinal chemistry (22-04-1999)“…5'-(Alkylthio)-substituted analogues of N6-benzyl- and N6-(3-iodobenzyl)adenosine were synthesized in 37-61% overall yields. The affinities of these compounds…”
Get full text
Journal Article -
8
Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A(2B) receptor for 2-(1-Hexynyl)adenosine
Published in Molecular pharmacology (01-12-2000)“…Adenosine A(2B) receptors are known as low-affinity receptors due to their modest-to-negligible affinity for adenosine and prototypic agonists. Despite…”
Get more information
Journal Article -
9
2,5'-Disubstituted adenosine derivatives: evaluation of selectivity and efficacy for the adenosine A(1), A(2A), and A(3) receptor
Published in Journal of medicinal chemistry (17-01-2002)“…Novel 2,5'-disubstituted adenosine derivatives were synthesized in good overall yields starting from commercially available guanosine. Binding affinities were…”
Get full text
Journal Article -
10
One-pot synthesis of [11C]ureas via triphenylphosphinimines
Published in Journal of labelled compounds & radiopharmaceuticals (30-03-2006)“…A series of 11C‐labeled ureas was prepared using a rapid and efficient one‐pot procedure. First, the intermediate [11C]phenylisocyanate was formed with…”
Get full text
Journal Article -
11
Functional role of adenosine receptor subtypes in the regulation of blood–brain barrier permeability: possible implications for the design of synthetic adenosine derivatives
Published in European journal of pharmaceutical sciences (01-05-2003)“…The objective of this investigation was to determine the functional role of adenosine receptor subtypes in the regulation of blood–brain barrier (BBB)…”
Get full text
Journal Article -
12
Medicinal chemistry of the human adenosine A3 receptor
Published in Drug development research (01-11-1998)“…Partial agonists and antagonists were synthesized and evaluated biologically for extended pharmacologic characterization of the human adenosine A3 receptor…”
Get full text
Journal Article Conference Proceeding